Kaplan-Meier analysis showed that the presence of NAT1 was significantly associated with increased OS in breast cancer patients and with DFS and OS in patients who received adjuvant endocrine therapy with tamoxifen. The gene discussed is NAT1; the disease is breast carcinoma.